FDA won’t require lengthy clinical trials for COVID-19 boosters
Future COVID-19 vaccine boosters won’t have to go through a traditional, lengthy clinical trial process to attain emergency use authorization in the U.S., according to a report in Reuters. An agency official, speaking to the … Read more